|1.||Frank, Joseph A: 5 articles (04/2011 - 03/2006)|
|2.||Arbab, Ali S: 4 articles (09/2008 - 03/2006)|
|3.||Oliva, Rafael: 3 articles (01/2014 - 07/2006)|
|4.||Rad, Ali M: 3 articles (09/2008 - 08/2007)|
|5.||Voronkova, Ya G: 2 articles (12/2015 - 12/2015)|
|6.||Popova, T N: 2 articles (12/2015 - 12/2015)|
|7.||Agarkov, A A: 2 articles (12/2015 - 12/2015)|
|8.||Sheng, Wang: 2 articles (01/2015 - 12/2013)|
|9.||Zhang, Fang: 2 articles (01/2015 - 12/2013)|
|10.||Cao, Minjun: 2 articles (01/2015 - 12/2013)|
05/01/2007 - "An in vivo animal study based on a porcine acute inflammation model following protamine sulfate instillation is performed to further evaluate the utility of SDEOCT system to delineate bladder morphology and inflammatory lesions as well as to detect subsurface blood flow. "
10/01/2008 - "Bladder inflammation in this experimental model of urothelial injury was not due to protamine sulfate alone. "
10/01/2008 - "We examined whether protamine sulfate alone could cause bladder inflammation or if the association of protamine sulfate and urine is needed for this condition. "
10/01/2008 - "Urine is necessary to provoke bladder inflammation in protamine sulfate induced urothelial injury."
11/01/2007 - "Bladder inflammation was induced in rats by intravesicular inoculation of protamine sulfate and lipopolysaccharide. "
01/01/1985 - "Thrombocytopenia accompanying a reaction to protamine sulfate."
03/01/1984 - "Similarly, the thrombocytopenia caused by intravenous administration was significantly lessened by protamine sulfate pretreatment (74% vs. 23% reduction; p less than 0.01). "
03/01/1984 - "Thrombocytopenia following protamine sulfate administration was the same in the two groups. "
07/01/1988 - "Platelet effects were capable of causing bleeding with standard or excess use of protamine sulfate, especially if platelet numbers were already decreased, as might occur in surgical procedures where thrombocytopenia commonly accompanies major blood loss and replacement. "
04/01/1997 - "The protamine variant +18RGD was less toxic, induced less thrombocytopenia, and was more effective in anticoagulation reversal than was standard protamine sulfate. "
11/15/2004 - "Upon infusion of the positively charged protein, protamine sulfate, the reverse was observed with mPF4(+/-) and mPF4(-/-) animals having improved thrombosis, with the hPF4(+) animals having worsened thrombus formation. "
04/01/1977 - "The serial-dilution protamine sulfate test is therefore capable of detecting both small local thrombi and serum-induced "hypercoagulability" without thrombosis in the dog model."
04/01/1977 - "In a dog model, combinations of venous-injury thrombosis, homologous serum-induced "hypercoagulability," and fibrinolytic blockade were evaluated to determine the factors involved in the generation of a positive serial-dilution protamine sulfate test. "
04/01/1977 - "Correlation of the serial-dilution protamine sulfate test with models of "hypercoagulability" and thrombosis in dogs."
01/01/1980 - "[Diagnostic value of the ethanol and protamine sulfate tests in thrombohemorrhagic syndromes and thrombosis]."
|4.||Wounds and Injuries (Trauma)
08/01/1985 - "Protamine sulfate given in high doses can inhibit angiogenesis in the granulation tissue generated in an open wound. "
10/01/1990 - "In patients not given protamine sulfate draining the wound lessened the incidence of wound hematoma (4.4% vs 8.6%), but this difference was not statistically significant (p = 0.1475). "
10/01/1990 - "The incidence of wound hematoma was 1.8% (n = 6) in patients given protamine sulfate and 6.5% (n = 24) in patients not given protamine sulfate, and this difference was significant (p = 0.0044). "
10/01/1990 - "During the past 6 years some of the authors frequently gave protamine sulfate to neutralize heparin, whereas others did not unless a patch was used or wound hemostasis was not readily obtained. "
10/01/1990 - "In patients given protamine sulfate the dose of protamine sulfate (15 to 45 mg vs 50 to 75 mg) had no statistically significant effect on the incidence of stroke (0.8% vs 2.0%, p = 0.6530) or wound hematoma (1.6% vs 1.0%, p = 1.000)."
|5.||Renal Insufficiency (Renal Failure)
05/01/2004 - "In addition, we review the use of LMWH in renal insufficiency, dosing in obese patients,and the importance of sulfate content in the efficacy of protamine sulfate as a reversing agent for LMWH."
10/07/2002 - "Conventional unfractionated heparin retains a role in the management of patients at high risk of bleeding, undergoing invasive procedures, and patients with renal failure owing to its shorter half-life, reversibility with protamine sulfate, and extrarenal metabolism. "
|1.||Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
|5.||DNA (Deoxyribonucleic Acid)
|1.||Cardiopulmonary Bypass (Heart-Lung Bypass)
|5.||Vasectomy (Vas Occlusion)